Compare Heron Therapeutics Inc (HRTX) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. Which is the better fit depends on your goals.
| HRTX | USIG | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Fixed Income |
52-Week High | $1.49 | $52.69 |
52-Week Low | $0.32 | $50.18 |
Enterprise Value | $168.21M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
